{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:22:42Z","timestamp":1764919362215,"version":"3.46.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670126","81670126","81670126","81670126"],"award-info":[{"award-number":["81670126","81670126","81670126","81670126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Central Guidance for Local Science and Technology Development Projects in Shanxi Province","award":["YDZJSX2021B009","YDZJSX2021B009","YDZJSX2021B009","YDZJSX2021B009"],"award-info":[{"award-number":["YDZJSX2021B009","YDZJSX2021B009","YDZJSX2021B009","YDZJSX2021B009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01725-9","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:18:54Z","timestamp":1748503134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the impact of CD4+ T cells and their subsets on relapse in AML patients during remission"],"prefix":"10.1007","volume":"25","author":[{"given":"Yingxia","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianbian","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"1725_CR1","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","volume":"368","author":"E Estey","year":"2006","unstructured":"Estey E, D\u00f6hner H. Acute myeloid leukaemia. Lancet Lond Engl. 2006;368:1894\u2013907.","journal-title":"Lancet Lond Engl"},{"key":"1725_CR2","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.","journal-title":"BMJ"},{"key":"1725_CR3","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41375-021-01131-6","volume":"35","author":"N Patkar","year":"2021","unstructured":"Patkar N, Kakirde C, Shaikh AF, Salve R, Bhanshe P, Chatterjee G, et al. Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML). Leukemia. 2021;35:1392\u2013404.","journal-title":"Leukemia"},{"key":"1725_CR4","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","volume":"138","author":"M Heuser","year":"2021","unstructured":"Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, et al. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2021;138:2753\u201367.","journal-title":"Blood"},{"key":"1725_CR5","unstructured":"[Chinese consensus on minimal residual disease detection and interpretation of patients with acute myeloid leukemia (2021)]. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2021;42:889\u201397."},{"key":"1725_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13073-022-01138-3","volume":"14","author":"K Thol","year":"2022","unstructured":"Thol K, Pawlik P, McGranahan N. Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution. Genome Med. 2022;14:137.","journal-title":"Genome Med"},{"key":"1725_CR7","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.3390\/cancers13184582","volume":"13","author":"G Riva","year":"2021","unstructured":"Riva G, Nasillo V, Ottomano AM, Bergonzini G, Paolini A, Forghieri F, et al. Multiparametric flow cytometry for MRD monitoring in hematologic malignancies: clinical applications and new challenges. Cancers. 2021;13:4582.","journal-title":"Cancers"},{"key":"1725_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.critrevonc.2004.06.004","volume":"56","author":"W Kern","year":"2005","unstructured":"Kern W, Schoch C, Haferlach T, Schnittger S. Monitoring of minimal residual disease in acute myeloid leukemia. Crit Rev Oncol Hematol. 2005;56:283\u2013309.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1725_CR9","unstructured":"[Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2023)]. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2023;44:705\u201312."},{"key":"1725_CR10","unstructured":"[Chinese guidelines for the diagnosis and treatment of relapsed\/refractory acute myelogenous leukemia (2021)]. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2021;42:624\u20137."},{"key":"1725_CR11","first-page":"293","volume":"29","author":"R-L Zhang","year":"2021","unstructured":"Zhang R-L, Zhou L-X, Tian H-J. Zhao L [research status of new targets mrd detection in acute myeloid leukemia recurrence\u2013review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021;29:293\u20136.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"1725_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/bjh.14823","volume":"179","author":"M Medinger","year":"2017","unstructured":"Medinger M, Passweg JR. Acute myeloid leukaemia genomics. Br J Haematol. 2017;179:530\u201342.","journal-title":"Br J Haematol"},{"key":"1725_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","volume":"15","author":"MR O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, et al. Acute myeloid leukemia, Version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 2017;15:926\u201357.","journal-title":"J Natl Compr Cancer Netw JNCCN."},{"key":"1725_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ajh.27561","volume":"100","author":"J Senapati","year":"2025","unstructured":"Senapati J, Kantarjian HM, Haddad FG, Short NJ, Borthakur G, Kanagal-Shamanna R, et al. Outcomes of patients with treated secondary acute myeloid leukemia: a high-risk subtype that warrants an independent prognostic designation. Am J Hematol. 2025;100:249\u201359.","journal-title":"Am J Hematol"},{"key":"1725_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood.2024024837","volume":"145","author":"Y Liu","year":"2025","unstructured":"Liu Y, Bollino DR, Bah OM, Strovel ET, Le TV, Zarrabi J, et al. A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia. Blood. 2025;145:486\u201396.","journal-title":"Blood"},{"key":"1725_CR16","doi-asserted-by":"publisher","first-page":"e839","DOI":"10.1016\/S2352-3026(24)00250-3","volume":"11","author":"NJ Short","year":"2024","unstructured":"Short NJ, Nguyen D, Jabbour E, Senapati J, Zeng Z, Issa GC, et al. Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial. Lancet Haematol. 2024;11:e839\u201349.","journal-title":"Lancet Haematol"},{"key":"1725_CR17","first-page":"190","volume":"23","author":"Z-R Yang","year":"2015","unstructured":"Yang Z-R, Zhu H-YDAW-M, Gao C-J, Yu L, Fu L-Y, et al. [Change and clinical significance of peripheral blood T-lymphocyte functional subsets in acute graft-versus-host disease]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23:190\u20134.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"1725_CR18","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/cancers14061508","volume":"14","author":"B Ljokjel","year":"2022","unstructured":"Ljokjel B, Haave H, Lybak S, Vintermyr OK, Helgeland L, Aarstad HJ. Tumor infiltration levels of CD3, Foxp3 (+) lymphocytes and CD68 macrophages at diagnosis predict 5-year disease-specific survival in patients with oropharynx squamous cell carcinoma. Cancers. 2022;14:1508.","journal-title":"Cancers"},{"key":"1725_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s43018-022-00338-5","volume":"3","author":"M Cohen","year":"2022","unstructured":"Cohen M, Giladi A, Barboy O, Hamon P, Li B, Zada M, et al. The interaction of CD4(+) helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response. Nat Cancer. 2022;3:303\u201317.","journal-title":"Nat Cancer"},{"key":"1725_CR20","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-08-3010","volume":"15","author":"MJ Szczepanski","year":"2009","unstructured":"Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, et al. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15:3325\u201332.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1725_CR21","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1182\/blood-2009-03-208181","volume":"114","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Bucher C, Munger ME, Highfill SL, Tolar J, Munn DH, et al. Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood. 2009;114:3793\u2013802.","journal-title":"Blood"},{"key":"1725_CR22","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1002\/ijc.29563","volume":"137","author":"Q Tao","year":"2015","unstructured":"Tao Q, Pan Y, Wang Y, Wang H, Xiong S, Li Q, et al. Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts. Int J Cancer. 2015;137:2384\u201393.","journal-title":"Int J Cancer"},{"key":"1725_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11:41.","journal-title":"Blood Cancer J"},{"key":"1725_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"1725_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151239","volume":"746","author":"Q Li","year":"2025","unstructured":"Li Q, He S, Li Z, Liu S, Mei X, Qi X, et al. A novel therapeutic strategy for leukopenia: Miltefosine activates the Ras\/MEK\/ERK pathway to promote neutrophil differentiation. Biochem Biophys Res Commun. 2025;746: 151239.","journal-title":"Biochem Biophys Res Commun"},{"key":"1725_CR26","doi-asserted-by":"crossref","unstructured":"Yin J, Luo J, Wang L, Liu L, Liu L. STAB1 Promotes Acute Myeloid Leukemia Progression by Activating the IKK\/NF-\u03baB Pathway and Increasing M2 Macrophage Polarization. Cancer Sci. 2025;","DOI":"10.1111\/cas.70044"},{"key":"1725_CR27","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1021\/acs.jmedchem.4c02076","volume":"68","author":"X Liang","year":"2025","unstructured":"Liang X, Huang Y, Ren H, Liu Q, Chen L, Zhao J, et al. Discovery of Novel RNA demethylase FTO inhibitors featuring an acylhydrazone scaffold with potent antileukemia activity. J Med Chem. 2025;68:2742\u201363.","journal-title":"J Med Chem"},{"key":"1725_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1158\/0008-5472.CAN-10-4627","volume":"72","author":"T Tanikawa","year":"2012","unstructured":"Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, N\u00fa\u00f1ez G, et al. Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res. 2012;72:420\u20139.","journal-title":"Cancer Res"},{"key":"1725_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41375-021-01375-2","volume":"36","author":"Y Xu","year":"2022","unstructured":"Xu Y, Mou J, Wang Y, Zhou W, Rao Q, Xing H, et al. Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway. Leukemia. 2022;36:403\u201315.","journal-title":"Leukemia"},{"key":"1725_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133\u201346.","journal-title":"Nat Rev Immunol"},{"key":"1725_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110989","volume":"39","author":"C Posseme","year":"2022","unstructured":"Posseme C, Llibre A, Charbit B, Bondet V, Rouilly V, Saint-Andr\u00e9 V, et al. Early IFN\u03b2 secretion determines variable downstream IL-12p70 responses upon TLR4 activation. Cell Rep. 2022;39: 110989.","journal-title":"Cell Rep"},{"key":"1725_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.170.3.827","volume":"170","author":"M Kobayashi","year":"1989","unstructured":"Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989;170:827\u201345.","journal-title":"J Exp Med"},{"key":"1725_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415:536\u201341.","journal-title":"Nature"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01725-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:52:45Z","timestamp":1764917565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01725-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1725"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01725-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"184"}}